We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drug developer Rigel Pharmaceuticals Inc. said Wednesday it will receive a $5 million milestone payment from Pfizer related to the development of a possible asthma drug. The Houston Chronicle
